1. Home
  2. STG vs PRLD Comparison

STG vs PRLD Comparison

Compare STG & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Sunlands Technology Group

STG

Sunlands Technology Group

HOLD

Current Price

$2.92

Market Cap

50.1M

Sector

Real Estate

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$3.87

Market Cap

529.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
STG
PRLD
Founded
2003
2016
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.1M
529.1M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
STG
PRLD
Price
$2.92
$3.87
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $5.67
AVG Volume (30 Days)
6.7K
★ 447.7K
Earning Date
05-21-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 23.21
EPS
★ N/A
N/A
Revenue
N/A
★ $12,140,000.00
Revenue This Year
N/A
$320.10
Revenue Next Year
N/A
$100.00
P/E Ratio
$1.10
★ N/A
Revenue Growth
N/A
★ 73.43
52 Week Low
$2.44
$1.15
52 Week High
$8.53
$6.83

Technical Indicators

Market Signals
Indicator
STG
PRLD
Relative Strength Index (RSI) 44.49 31.54
Support Level $2.82 $3.40
Resistance Level $3.62 $4.10
Average True Range (ATR) 0.11 0.33
MACD 0.02 -0.11
Stochastic Oscillator 59.96 2.15

Price Performance

Historical Comparison
STG
PRLD

About STG Sunlands Technology Group

Sunlands Technology Group operates in China's adult online education market and adult personal interest learning market through its online platforms. The Group has a deep understanding of the educational needs of its prospective students and offers solutions to help them achieve their goals. It provides online professional courses and educational content, including interest, professional skills, professional certification preparation courses, and degree- or diploma-oriented post-secondary courses. The Group adopts a counseling-oriented sales and marketing approach to offer education solutions based on students' backgrounds and goals, delivering adult online education and personal interest learning through extensive course and content offerings.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: